Pyridoxamine

DIETARY_SUPPLEMENT3 trials

Sponsors

Terauchi Masakazu, University of Kansas Medical Center, Maastricht University Medical Center

Conditions

Abdominal Obesity Metabolic SyndromeKidney Stonesmenopausal disorder with psychological symptoms

Phase 2

A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria

WithdrawnNCT00490113

University of Kansas Medical CenterKidney Stones

Start: 2007-01-31Updated: 2017-01-05

Phase 3

Pyridoxamine for menopausal disorder

Active, not recruitingJPRN-jRCTs031220256

Terauchi Masakazumenopausal disorder with psychological symptoms

Start: 2023-10-19Target: 50Updated: 2026-06-29

Unknown Phase

Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity

CompletedNCT02954588

Maastricht University Medical CenterAbdominal Obesity Metabolic Syndrome

Start: 2016-10-14End: 2020-08-08Updated: 2020-10-01

Related Papers

Quantification of the B6 vitamers in human plasma and urine in a study with pyridoxamine as an oral supplement; pyridoxamine as an alternative for pyridoxine

Clinical Nutrition2021-06-1022 citations